Rapid identification of reactive cysteine residues for site-specific labeling of antibody-Fabs

被引:121
作者
Junutula, Jagath R. [1 ]
Bhakta, Sunil [1 ]
Raab, Helga [1 ]
Ervin, Karen E. [1 ]
Eigenbrot, Charles [1 ]
Vandlen, Richard [1 ]
Scheller, Richard H. [1 ]
Lowman, Henry B. [1 ]
机构
[1] Genentech Inc, San Francisco, CA 94080 USA
关键词
antibody-Fabs; phage display; PHESELECTOR; reactive thiols; site-specific conjugation;
D O I
10.1016/j.jim.2007.12.011
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Cysteines with reactive thiol groups are attractive tools for site-specific labeling of proteins. Engineering a reactive cysteine residue into proteins with multiple disulfide bonds is often a challenging task as it may interfere with structural and functional properties of the protein. Here we developed a phage display-based biochemical assay, PHESELECTOR (Phage ELISA for Selection of Reactive Thiols) to rapidly screen reactive thiol groups on antibody fragments without interfering with their antigen binding, using trastuzumab-Fab (hu4D5Fab) as a model system. The solvent accessibility values for all the amino acid residues in the hu4D5Fab were calculated using available crystal structure information. Serine, alanine and valine residues with highest solvent accessibility values were selected and tested to compare structure-based design with the PHESELECTOR biochemical method. Cysteine substitutions at partially solvent-accessible alanine or valine residues exhibited better thiol reactivity values than substitutions at serine residues. The poor correlation between fractional solvent accessibility and thiol reactivity of the engineered hu4D5Fab variants indicated the value of PHESELECTOR biochemical assay to identify reactive thiol groups on the antibody-Fab surface. Mass spectrometric analysis of biotinylated ThioFab (Fab with engineered cysteine) variants confirmed that conjugation occurred only at the engineered cysteine thiols of either light or heavy chains. ThioFabs with engineered cysteine residues in the constant domains (CL and CH1) should allow universal application for site-specific conjugation of antibody-Fabs. (C) 2007 Elsevier B.V. All rights reserved.
引用
收藏
页码:41 / 52
页数:12
相关论文
共 37 条
[11]   Albumin binding as a general strategy for improving the pharmacokinetics of proteins [J].
Dennis, MS ;
Zhang, M ;
Meng, YG ;
Kadkhodayan, M ;
Kirchhofer, D ;
Combs, D ;
Damico, LA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (38) :35035-35043
[12]   Enhanced activity of monomethylauristatin F through monoclonal antibody delivery: Effects of linker technology on efficacy and toxicity [J].
Doronina, SO ;
Mendelsohn, BA ;
Bovee, TD ;
Cerveny, CG ;
Alley, SC ;
Meyer, DL ;
Oflazoglu, E ;
Toki, BE ;
Sanderson, RJ ;
Zabinski, RF ;
Wahl, AF ;
Senter, PD .
BIOCONJUGATE CHEMISTRY, 2006, 17 (01) :114-124
[13]   X-RAY STRUCTURES OF THE ANTIGEN-BINDING DOMAINS FROM 3 VARIANTS OF HUMANIZED ANTI-P185HER2 ANTIBODY 4D5 AND COMPARISON WITH MOLECULAR MODELING [J].
EIGENBROT, C ;
RANDAL, M ;
PRESTA, L ;
CARTER, P ;
KOSSIAKOFF, AA .
JOURNAL OF MOLECULAR BIOLOGY, 1993, 229 (04) :969-995
[14]  
GARRARD LJ, 1999, BIOTECHNOLOGY NY, V9, P1373
[15]   Sequence plasticity in the antigen-binding site of a therapeutic anti-HER2 antibody [J].
Gerstner, RB ;
Carter, P ;
Lowman, HB .
JOURNAL OF MOLECULAR BIOLOGY, 2002, 321 (05) :851-862
[16]   SPECIFIC CHEMICAL MODIFICATION OF PROTEINS [J].
GLAZER, AN .
ANNUAL REVIEW OF BIOCHEMISTRY, 1970, 39 :101-&
[17]   Effects of drug loading on the antitumor activity of a monoclonal antibody drug conjugate [J].
Hamblett, KJ ;
Senter, PD ;
Chace, DF ;
Sun, MMC ;
Lenox, J ;
Cerveny, CG ;
Kissler, KM ;
Bernhardt, SX ;
Kopcha, AK ;
Zabinski, RF ;
Meyer, DL ;
Francisco, JA .
CLINICAL CANCER RESEARCH, 2004, 10 (20) :7063-7070
[18]   DIRECT SELECTION FOR A CATALYTIC MECHANISM FROM COMBINATORIAL ANTIBODY LIBRARIES [J].
JANDA, KD ;
LO, CHL ;
LI, TY ;
BARBAS, CF ;
WIRSCHING, P ;
LERNER, RA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (07) :2532-2536
[19]   Rab14 is involved in membrane trafficking between the Golgi complex and endosomes [J].
Junutula, JR ;
De Maziére, AM ;
Peden, AA ;
Ervin, KE ;
Advani, RJ ;
van Dijk, SM ;
Klumperman, J ;
Scheller, RH .
MOLECULAR BIOLOGY OF THE CELL, 2004, 15 (05) :2218-2229
[20]   Assembling of engineered IgG-binding protein on gold surface for highly oriented antibody immobilization [J].
Kanno, S ;
Yanagida, Y ;
Haruyama, T ;
Kobatake, E ;
Aizawa, M .
JOURNAL OF BIOTECHNOLOGY, 2000, 76 (2-3) :207-214